Augustine doses first patient in Phase I trial for AGT-100216
27 May 2025 //
GLOBENEWSWIRE
Augustine Doses First Patient in CMT Ph 1 Trial of AGT-100216
27 May 2025 //
GLOBENEWSWIRE
Augustine Appoints CSO Rie Hansen And Opens Denmark Office
21 May 2025 //
GLOBENEWSWIRE
Augustine Therapeutics appoints Rie Schultz Hansen as CSO
21 May 2025 //
GLOBENEWSWIRE
Augustine Therapeutics adds Virginie as CFO & Dr. Andy as CBO
30 Apr 2025 //
GLOBENEWSWIRE
Augustine Therapeutics appoints Pascale Witz as Chair of Board
09 Apr 2025 //
GLOBENEWSWIRE
Augustine Therapeutics names Pascale Witz Chair of Board
09 Apr 2025 //
GLOBENEWSWIRE
Augustine Therapeutics raises EUR 78M / USD 85M in Series A round
24 Mar 2025 //
GLOBENEWSWIRE
Augustine Therapeutics Names Gerhard Koenig CEO as It Enters Clinic
13 Feb 2025 //
GLOBENEWSWIRE